These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15274037)

  • 1. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
    Serretti A; Cusin C; Rossini D; Artioli P; Dotoli D; Zanardi R
    Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):36-40. PubMed ID: 15274037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
    Serretti A; Zanardi R; Rossini D; Cusin C; Lilli R; Smeraldi E
    Mol Psychiatry; 2001 Sep; 6(5):586-92. PubMed ID: 11526473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders.
    Chotai J; Serretti A; Lorenzi C
    Neuropsychobiology; 2005; 51(1):3-9. PubMed ID: 15627807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders.
    Serretti A; Mandelli L; Lorenzi C; Pirovano A; Olgiati P; Colombo C; Smeraldi E
    Psychiatry Res; 2007 Jan; 149(1-3):185-93. PubMed ID: 17157919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
    Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
    Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
    Zanardi R; Serretti A; Rossini D; Franchini L; Cusin C; Lattuada E; Dotoli D; Smeraldi E
    Biol Psychiatry; 2001 Sep; 50(5):323-30. PubMed ID: 11543734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
    Kato M; Fukuda T; Wakeno M; Fukuda K; Okugawa G; Ikenaga Y; Yamashita M; Takekita Y; Nobuhara K; Azuma J; Kinoshita T
    Neuropsychobiology; 2006; 53(4):186-95. PubMed ID: 16874005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.
    Serretti A; Artioli P; Zanardi R; Lorenzi C; Rossini D; Cusin C; Arnoldi A; Catalano M
    Psychopharmacology (Berl); 2004 Aug; 174(4):504-11. PubMed ID: 15248044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder.
    You JS; Hu SY; Chen B; Zhang HG
    Psychiatr Genet; 2005 Mar; 15(1):7-11. PubMed ID: 15722951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders.
    Cusin C; Serretti A; Lattuada E; Lilli R; Lorenzi C; Mandelli L; Pisati E; Smeraldi E
    J Psychiatr Res; 2001; 35(4):217-23. PubMed ID: 11578639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin transporter gene and effectiveness of SSRIs.
    Serretti A; Kato M
    Expert Rev Neurother; 2008 Jan; 8(1):111-20. PubMed ID: 18088204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment.
    Takahashi H; Yoshida K; Ito K; Sato K; Kamata M; Higuchi H; Shimizu T; Ito K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):477-81. PubMed ID: 12208565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
    Serretti A; Zanardi R; Cusin C; Rossini D; Lorenzi C; Smeraldi E
    Eur Neuropsychopharmacol; 2001 Oct; 11(5):375-80. PubMed ID: 11597824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural network analysis in pharmacogenetics of mood disorders.
    Serretti A; Smeraldi E
    BMC Med Genet; 2004 Dec; 5():27. PubMed ID: 15588300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
    Serretti A; Zanardi R; Franchini L; Artioli P; Dotoli D; Pirovano A; Smeraldi E
    Pharmacogenetics; 2004 Sep; 14(9):607-13. PubMed ID: 15475734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between SERTPR and stressful life events on response to antidepressant treatment.
    Mandelli L; Marino E; Pirovano A; Calati R; Zanardi R; Colombo C; Serretti A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):64-7. PubMed ID: 18815011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.